Mark Borns, Pharm D
Evidence And Outcomes Liaison @ Eli Lilly and Company
About Mark Borns, Pharm D
Mark Borns, Pharm D, serves as an Evidence and Outcomes Liaison at Eli Lilly and Company, where he has worked since 2019. He possesses expertise in pharmacoeconomics and has held various roles in the pharmaceutical industry, focusing on enhancing customer experiences and developing strategic partnerships.